Valneva SE (VALN) Interest Coverage Ratio (QoQ) (2021 - 2026)
Valneva SE (VALN) Interest Coverage Ratio (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - |
| 10 | Valneva SE | 837.53 Mn | 717.75 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 507.18% |
| Dec 31, 2025 | 82.40% |
| Sep 30, 2025 | -884.66% |
| Jun 30, 2025 | -166.16% |
| Mar 31, 2025 | 130.07% |
| Dec 31, 2024 | -52.29% |
| Sep 30, 2024 | -80.01% |
| Jun 30, 2024 | 87.51% |
| Mar 31, 2024 | -1,291.68% |
| Dec 31, 2023 | -166.88% |
| Sep 30, 2023 | 179.04% |
| Jun 30, 2023 | -140.46% |
| Mar 31, 2023 | 287.29% |
| Dec 31, 2022 | 90.33% |
| Sep 30, 2022 | -147.37% |
| Jun 30, 2022 | 871.07% |
| Mar 31, 2022 | -47.49% |
| Dec 31, 2021 | 108.33% |
| Sep 30, 2021 | -720.04% |
| Jun 30, 2021 | 112.93% |